Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of complication rates after transvaginal ultrasound-guided oocyte pick-up procedures with respect to ovarian response

  • Gungor, Nur Dokuzeylul (Department of Reproductive Endocrinology and IVF Center, BAU Goztepe Medical Park Hospital) ;
  • Gurbuz, Tugba (Department of Obstetrics and Gynecology, Medistate Hospital) ;
  • Onal, Murat (Department of Reproductive Endocrinology and IVF Center, Gynolife Hospital)
  • Received : 2021.08.04
  • Accepted : 2022.02.04
  • Published : 2022.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The aim of this study was to compare the complication rates of oocyte pick-up (OPU) procedures via transvaginal ultrasonography in patients with different levels of ovarian reserve. Methods: In total, 789 patients who underwent OPU procedures for in vitro fertilization (IVF) were included in the study. Results: Individuals with normal ovarian reserve had a 2.947-fold higher risk of complications in OPU procedures than individuals with low ovarian reserve, and individuals with high ovarian reserve had a 7.448-fold higher risk of complications than individuals with low ovarian reserve. In addition, a higher number of IVF trials was associated with an increased risk of complications. Conclusion: The results of this study show that OPU has a higher risk of complications, particularly severe pain, in patients with high ovarian reserve. It is thought that complications can be reduced by preferring mild stimulation in patients with high ovarian reserve. Collecting fewer oocytes is also associated with a lower risk of complications from OPU. Even if a patient's reserve is very good, fewer and higher-quality oocytes should be targeted with the use of the lowest possible dose of drugs.

Keywords

References

  1. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 2012;9:e1001356. https://doi.org/10.1371/journal.pmed.1001356
  2. Drakopoulos P, Bardhi E, Boudry L, Vaiarelli A, Makrigiannakis A, Esteves SC, et al. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept. Ther Adv Reprod Health 2020;14:2633494120941480.
  3. Rani K, Paliwal S. A brief review on in-vitro fertilization (IVF): an advanced and miraculous gateway for infertility treatments. World J Pharm Sci 2014;3:647-58.
  4. Levi-Setti PE, Cirillo F, Scolaro V, Morenghi E, Heilbron F, Girardello D, et al. Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program. Fertil Steril 2018;109:1038-43. https://doi.org/10.1016/j.fertnstert.2018.02.002
  5. Schulman JD, Dorfmann A, Jones S, Joyce B, Hanser J. Outpatient in vitro fertilization using transvaginal oocyte retrieval and local anesthesia. N Engl J Med 1985;312:1639.
  6. Maxwell KN, Cholst IN, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril 2008;90:2165-71. https://doi.org/10.1016/j.fertnstert.2007.10.065
  7. Aragona C, Mohamed MA, Espinola MS, Linari A, Pecorini F, Micara G, et al. Clinical complications after transvaginal oocyte retrieval in 7,098 IVF cycles. Fertil Steril 2011;95:293-4. https://doi.org/10.1016/j.fertnstert.2010.07.1054
  8. Muzii L, Marana R, Caruana P, Catalano GF, Mancuso S. Laparoscopic findings after transvaginal ultrasound-guided aspiration of ovarian endometriomas. Hum Reprod 1995;10:2902-3. https://doi.org/10.1093/oxfordjournals.humrep.a135815
  9. Pargianas M, Salta S, Fiorentzis S, Kalampoki LG, Beck R, Vizziello D, et al. Complications in oocyte retrieval. In: Malvasi A, Baldini D. editors. Pick up and oocyte management. Cham: Springer; 2020. p. 305-37.
  10. Leung AS, Dahan MH, Tan SL. Techniques and technology for human oocyte collection. Expert Rev Med Devices 2016;13:701-3. https://doi.org/10.1080/17434440.2016.1205485
  11. Rose BI. Approaches to oocyte retrieval for advanced reproductive technology cycles planning to utilize in vitro maturation: a review of the many choices to be made. J Assist Reprod Genet 2014;31: 1409-19. https://doi.org/10.1007/s10815-014-0334-9
  12. Vaiarelli A, Cimadomo D, Ubaldi N, Rienzi L, Ubaldi FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol 2018;30:155-62. https://doi.org/10.1097/GCO.0000000000000452
  13. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, et al. Management of poor responders in IVF. Reprod Biomed Online 2005;10:235-46. https://doi.org/10.1016/S1472-6483(10)60946-7
  14. Blumenfeld Z. What is the best regimen for ovarian stimulation of poor responders in ART/IVF? Front Endocrinol (Lausanne) 2020; 11:192. https://doi.org/10.3389/fendo.2020.00192
  15. Blumenfeld Z. Premature ovarian failure: etiology and possible prevention. Expert Rev Endocrinol Metab 2009;4:173-81. https://doi.org/10.1586/17446651.4.2.173
  16. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11:391-410. https://doi.org/10.1093/humupd/dmi012
  17. Lee HC, Lyndon A, Blumenfeld YJ, Dudley RA, Gould JB. Antenatal steroid administration for premature neonates in California. Obstet Gynecol 2011;117:603-9. https://doi.org/10.1097/AOG.0b013e31820c3c9b
  18. Skillern A, Rajkovic A. Recent developments in identifying genetic determinants of premature ovarian failure. Sex Dev 2008;2:228-43. https://doi.org/10.1159/000152039
  19. Barrenetxea G, Agirregoikoa JA, Jimenez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-53. https://doi.org/10.1016/j.fertnstert.2007.03.088
  20. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain (VAS Pain), numeric rating scale for pain (NRS pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S240-52. https://doi.org/10.1002/acr.20543
  21. Jirge PR. Ovarian reserve tests. J Hum Reprod Sci 2011;4:108-13. https://doi.org/10.4103/0974-1208.92283
  22. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Reprint of: Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2019;112(4 Suppl1):e183-8.
  23. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124: 601-9. https://doi.org/10.1530/reprod/124.5.601
  24. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-5. https://doi.org/10.1016/j.fertnstert.2010.04.006
  25. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-71. https://doi.org/10.1093/humrep/17.12.3065
  26. Kim SW, Kim YJ, Shin JH, Kim H, Ku SY, Suh CS, et al. Correlation between ovarian reserve and incidence of ectopic pregnancy after in vitro fertilization and embryo transfer. Yonsei Med J 2019;60: 285-90. https://doi.org/10.3349/ymj.2019.60.3.285
  27. Ozaltin S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol 2018;89:1-6. https://doi.org/10.5603/GP.a2018.0001
  28. Siristatidis C, Chrelias C, Alexiou A, Kassanos D. Clinical complications after transvaginal oocyte retrieval: a retrospective analysis. J Obstet Gynaecol 2013;33:64-6. https://doi.org/10.3109/01443615.2012.721818
  29. Bodri D, Guillen JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online 2008;17:237-43. https://doi.org/10.1016/S1472-6483(10)60200-3
  30. Tsai YC, Lin MY, Chen SH, Chung MT, Loo TC, Huang KF, et al. Vaginal disinfection with povidone iodine immediately before oocyte retrieval is effective in preventing pelvic abscess formation without compromising the outcome of IVF-ET. J Assist Reprod Genet 2005;22:173-5. https://doi.org/10.1007/s10815-005-4915-5
  31. Weinreb EB, Cholst IN, Ledger WJ, Danis RB, Rosenwaks Z. Should all oocyte donors receive prophylactic antibiotics for retrieval? Fertil Steril 2010;94:2935-7. https://doi.org/10.1016/j.fertnstert.2010.05.054
  32. Liberty G, Hyman JH, Eldar-Geva T, Latinsky B, Gal M, Margalioth EJ. Ovarian hemorrhage after transvaginal ultrasonographically guided oocyte aspiration: a potentially catastrophic and not so rare complication among lean patients with polycystic ovary syndrome. Fertil Steril 2010;93:874-9. https://doi.org/10.1016/j.fertnstert.2008.10.028
  33. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of > 1000 oocyte retrievals. Hum Reprod 2006;21:3235-40. https://doi.org/10.1093/humrep/del278
  34. Singhal H, Premkumar PS, Chandy A, Kunjummen AT, Kamath MS. Patient experience with conscious sedation as a method of pain relief for transvaginal oocyte retrieval: a cross sectional study. J Hum Reprod Sci 2017;10:119-23. https://doi.org/10.4103/jhrs.JHRS_113_16
  35. Liang T, Ruetz K, Haakman O, Vilos A, Vilos G, Abu-Rafea B. Impact of class III obesity on outcomes and complications of transvaginal ultrasound-guided oocyte pickup. F S Rep 2020;1:270-6.
  36. Awonuga A, Waterstone J, Oyesanya O, Curson R, Nargund G, Parsons J. A prospective randomized study comparing needles of different diameters for transvaginal ultrasound-directed follicle aspiration. Fertil Steril 1996;65:109-13. https://doi.org/10.1016/S0015-0282(16)58036-4